Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dopamine receptor D2S (short isoform) is one of two main splice variants of the dopamine D2 receptor, a member of the G protein-coupled receptor (GPCR) family. The D2S isoform is generated by alternative splicing and differs from the long form (D2L) by lacking a 29-amino acid segment in the third intracellular loop. It functions primarily as an inhibitory autoreceptor on dopaminergic neurons; it regulates synthesis/release via Gi/o-mediated pathways that decrease cAMP production and neuronal excitability.
Gi/o protein activation, inhibition of adenylyl cyclase, reduction of cAMP levels, inhibition of voltage-gated calcium channels, activation of G-protein inwardly rectifying potassium channels (GIRK)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine receptor D2S (D2S).